COVID-19 March 24, 2020 Federal Update

Legislation
Supplemental III – “COVID-III”

The hope continues to be that a deal can come together, that a time agreement can be reached, and that the Senate can vote expeditiously – if not yesterday night, then certainly by today. Absent any deal, the Senate would vote on cloture on the motion to proceed to the COVID-III vehicle one hour after convening tomorrow.

If the Senate passes the package today, the House could pass by unanimous consent on Thursday. If unanimous consent isn’t achievable, the fallback is the suspension calendar on Friday. All of this is dependent on how quickly a deal is reached and text is released.


Process and Politics:

Multiple caucus conference calls were held yesterday and it seems that both caucuses are attempting to marshal their members toward acceptance of passing the bill by unanimous consent in the House. Speaker Pelosi and other House leadership have indicated they would be willing to pass the bill in the House under unanimous consent, but only if the end product is acceptable.


Policy:

Multiple updated drafts of the bill have been circulated yesterday. However, it’s unclear as of right now, as negotiations are still ongoing, what provisions in the draft bill are completely set and what is being further negotiated. As with previous big deals, nothing is final until everything is final . All policies previously discussed continue to be on the table and could be part of a final deal. CARES text (as of earlier today) here. Latest information indicates a final bill may include the following:

  • $1,200 in direct payments, $500 per child with income limitations and restriction;
  • Early withdrawals from retirement accounts without penalty;
  • Expansion of unemployment insurance (includes eligibility to self-employed, contract employees) for 4 months;
  • Delay in payroll taxes by one year, payable over two years;
  • Net Operating Loss from tax years 2018, 2019, or 2020 may be carried back five years;
  • Small business bridge loans to companies with 500 employees or fewer with a maximum loan of $10 million, administered by 7(a) lenders;
  • $100 billion for hospitals with $50 billion in extra support for combatting COVID-19;
  • Expansion of HSAs to cover over the counter medicine;
  • Telehealth flexibility;
  • Suspension of the Medicare sequester through December 31, 2020. 
  • Liability protections for doctors practicing across state lines;
  • Treasury-administered loans for distressed industries, including $50 billion for passenger airlines, $8 billion for cargo carriers, $10 billion for AIP, with restrictions and a certain amount of oversight (unclear what that is until we see text).

Passed Legislation

Supplemental II – Families First Coronavirus Response Act (HR 6201)

The Senate passed the bill 90-8 Wednesday afternoon and the President signed the bill into law that evening. Bill text here. Factsheet here. Bill section by section here. A summary of paid leave provisions, incorporating changes made by technical correction, is  here.

Supplemental I – Coronavirus Supplemental

Signed by the President March 6. Text here, summary here.


Members of Congress in Quarantine or Treatment

Tested Positive (3): Sen. Rand Paul (R-KY), Rep. Ben McAdams (D-UT), Rep. Mario Diaz-Balart (R-FL)

Currently Self-Quarantined (26): Rep. Paul Gosar (R-AZ), Rep. Julia Brownley (D-CA), Rep. Jason Crow (D-CO), Rep. Matt Gaetz (R-FL), Rep. Mario Diaz-Balart (R-FL), Rep. Doug Collins (R-GA), Rep. Steve Scalise (R-LA), Rep. Ann Wagner (R-MO), Rep. Sharice Davids (D-KS), Rep. Ben Ray Luján (D-NM), Rep. Kathleen Rice (D-NY), Rep. Kendra Horn (D-OK), Rep. Matt Cartwright (D-PA), Rep. Ben McAdams (D-UT), Rep. Gwen Moore (D-WI), Rep. Frederica Wilson (D-FL), Rep. Stephanie Murphy (D-FL), Rep. Drew Ferguson (R-GA), Rep. Joe Cunningham (D-SC), Rep. Tom Cole (R-OK), Rep. David Schweikert (R-AZ), Rep. Anthony Brindisi (D-NY), Rep. David Price (D-NC), Rep. Andy Kim (D-NJ), Sen. Rick Scott (R-FL), Sen. Cory Gardner (R-CO), Sen. Mike Lee (R-UT), Sen. Mitt Romney (R-UT)

Completed Quarantine (4): Sen. Ted Cruz (R-TX), Rep. Mark Meadows (R-NC), Sen. Lindsay Graham (R-SC), Rep. Don Beyer (D-VA)

August 10, 2026
Award recipients will be recognized at the Golden Helix Awards Ceremony on August 25 ATLANTA, Ga. – Georgia Life Sciences today announced the recipients of the 2026 Golden Helix Awards, recognizing the individuals, organizations, partnerships, and investments that are advancing innovation, improving patient care, strengthening Georgia's economy, and shaping the future of the state's life sciences ecosystem. The honorees will be celebrated during the Georgia Life Sciences Summit Welcome Reception and Golden Helix Awards Ceremony on Tuesday, August 25, at the Sandy Springs Performing Arts Center, kicking off Georgia's premier gathering of life sciences leaders ahead of the Summit on Wednesday, August 26. "For nearly two decades, the Golden Helix Awards have celebrated the people and organizations whose vision, collaboration, and commitment continue to elevate Georgia as a global leader in life sciences," said Maria Thacker Goethe, President & CEO of Georgia Life Sciences. "This year's recipients represent the extraordinary innovation taking place across our state—from groundbreaking research and transformative investments to workforce development and community impact. We are proud to recognize their achievements and the lasting difference they are making for patients, our economy, and the future of healthcare." 2026 Golden Helix Award Honorees Phoenix Award · Micron Biomedical, Emory University, and CDC – Industry-Academic Partnership Innovation Awards · Dr. Kyle Johnsen, University of Georgia · Focused Cryo Community Awards · Angela Gill Nelms, Biolocity · Frugal Science Academy · Jessica King Holden, Gwinnett Regional Science, Engineering + Innovation Fair · Dr. Marlo Vernon, Augusta University Deal of the Year Awards Economic Development · UCB · Shriners Children's Research Institute and Georgia Tech Acquisition · LymphaTech & Tactile Medical · Avanos Medical Financing · Altesa BioSciences Federal Grant · HEAL: Healthy Ameliorated Lymphatics, Georgia Institute of Technology · Manus & U.S. Department of Health and Human Services Administration for Strategic Preparedness and Response (HHS/ASPR) Emerging Leader of the Year · Dr. Ryan Devine, Medical Innovation Hub, Georgia Tech Legislator of the Year · Rep. Matt Dubnik (R-29) Teacher of the Year · Ana White, DeKalb High School of Technology North at Cross Keys The Golden Helix Awards recognize excellence across Georgia's life sciences ecosystem, honoring breakthrough scientific discoveries, strategic partnerships, commercial achievements, community leadership, and investments that strengthen the state's position as a national leader in biotechnology, medical technology, pharmaceuticals, research, and advanced manufacturing. The awards ceremony serves as the opening event of the 2026 Georgia Life Sciences Summit, bringing together executives, researchers, entrepreneurs, investors, and healthcare leaders, and academic institutions from across the state to celebrate innovation and explore opportunities shaping the future of Georgia's life sciences industry. The Georgia Life Sciences Summit will take place on Wednesday, August 26, at the Sandy Springs Performing Arts Center, featuring nationally recognized speakers, executive panels, CEO spotlights, networking opportunities, and the Solutions Corridor showcasing organizations driving the industry's continued growth. To learn more about the Georgia Life Sciences Summit or to register, visit https://www.galifesciences.org/summit.
August 7, 2026
One of the biggest benefits of becoming a Georgia Life Sciences Student Member is access to discounted registration for Georgia's premier life sciences conference—bringing together CEOs, researchers, entrepreneurs, investors, and innovators from across the state. Better yet, Student Membership is only $25 per year , making it one of the best investments you can make in your future. The Georgia Life Sciences Emerging Leaders Network (ELN) is the official student membership community of Georgia Life Sciences, created to connect students, postdoctoral researchers, and early-career professionals with Georgia's thriving life sciences ecosystem. As an ELN member, you'll build meaningful peer-to-peer relationships, engage with industry leaders, explore career opportunities, and gain access to professional development programs designed to help you launch a successful career in the life sciences. As a member, you'll have opportunities to: Connect with fellow students, postdocs, and emerging professionals from across Georgia. Expand your network through peer-to-peer engagement and professional networking events. Learn from industry leaders and gain exposure to Georgia's life sciences ecosystem. Participate in workforce and career development programming. Access Career Connections Student members also receive exclusive access to the Georgia Life Sciences Career Connections LinkedIn Group , where you can: Discover internships and job opportunities. Connect with employers, recruiters, and industry professionals. Stay informed about career fairs, networking events, and workforce initiatives. Engage with a growing community of future life sciences leaders. Student Member Benefits Georgia Life Sciences Student Membership: $25/year Georgia Life Sciences Summit Registration: $150 Access to the Emerging Leaders Network Career Connections LinkedIn Group Networking events and professional development opportunities Industry news, workforce resources, and member communications Whether you're exploring careers in biotechnology, medical devices, pharmaceuticals, diagnostics, digital health, or research, Georgia Life Sciences connects you to the people and opportunities that can help shape your future. Join today . Build your network. Advance your career.
August 6, 2026
From breakthrough therapeutics to next-generation medical technologies, tomorrow's innovators take the stage at the Georgia Life Sciences Summit. Sponsored by Johnson & Johnson, the Startup Showcase will highlight eight of Georgia's most promising early-stage life sciences companies as they present their innovations during the Summit Luncheon on August 26. These emerging companies are tackling some of healthcare's biggest challenges across therapeutics, diagnostics, AI, and medical technology, while demonstrating the depth of innovation taking place throughout Georgia's life sciences ecosystem. Meet the 2026 Startup Showcase Companies: Abundance Biopharma Corporation Athna Biotech Atomistic Insights NovAb Nytricx Oridivus TremeBio YoungHeartValve Following the presentations, each company will participate in a live investor Q&A featuring an exceptional panel of venture leaders: Emily Dinu, Numinous Capital John Gutierrez, Ascenta Capital Dr. Emma Heckenberg, Solas BioVentures Patrick Jordan, NovaQuest Capital Management Tim Opler, Stifel Whether you're an investor looking for the next breakthrough, a corporate leader seeking innovative partners, or simply interested in the future of life sciences, the Startup Showcase offers a front-row seat to the companies poised to shape what's next. Join us August 25–26 at the Georgia Life Sciences Summit and discover the next generation of innovators driving Georgia's life sciences economy.
MORE POSTS